Gilead Sciences Announces Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Gilead Sciences (GILD) PT Raised to $86 at Jefferies
October 28, 2022 8:59 AM EDTJefferies analyst Michael Yee raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $78.00) while maintaining a Buy rating following results.
The analyst commented, "GILD put up a good Q across the board and esp strong Veklury Covid quarter... More
Gilead Sciences (GILD) Tops Q3 EPS by 38c
October 27, 2022 4:01 PM EDTGilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.90, $0.38 better than the analyst estimate of $1.52. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.13 billion.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
... More